First reported overexpression of AURKA in melanoma.
Targeting AURKA inhibits melanoma growth in vitro and in vivo.
Further found miR-137 suppressed cell growth by binding to AURKA 3′UTR.
Re-expression of AURKA rescued miR-137-mediated suppression.
miR-137-AURKA axis may be potential therapeutic targets of melanoma.